These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7684591)

  • 1. Restricted expression of Ki-67 in cholesteatoma epithelium.
    Mayot D; Béné MC; Perrin C; Faure GC
    Arch Otolaryngol Head Neck Surg; 1993 Jun; 119(6):656-8. PubMed ID: 7684591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study.
    Ergün S; Zheng X; Carlsöö B
    Acta Otolaryngol; 1994 May; 114(3):295-302. PubMed ID: 7521107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunocytochemical study of cytokeratin expression in human middle ear cholesteatoma.
    Chao WY; Huang CC
    Arch Otorhinolaryngol; 1989; 246(1):37-42. PubMed ID: 2472127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues.
    Broekaert D; Coucke P; Leperque S; Ramaekers F; Van Muijen G; Boedts D; Leigh I; Lane B
    Ann Otol Rhinol Laryngol; 1992 Nov; 101(11):931-8. PubMed ID: 1280020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin expression in cholesteatoma matrix, meatal epidermis and middle ear epithelium. A preliminary report.
    van Blitterswijk CA; Grote JJ
    Acta Otolaryngol; 1988; 105(5-6):529-32. PubMed ID: 2456666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperproliferation-associated keratin expression in human middle ear cholesteatoma.
    Bujía J; Schilling V; Holly A; Stammberger M; Kastenbauer E
    Acta Otolaryngol; 1993 May; 113(3):364-8. PubMed ID: 7685977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of involucrin in human middle ear cholesteatoma.
    Chao WY; Huang CC
    Am J Otol; 1989 Sep; 10(5):385-8. PubMed ID: 2683803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma.
    Bujía J; Holly A; Schilling V; Negri B; Pitzke P; Schulz P
    Laryngoscope; 1993 Mar; 103(3):326-9. PubMed ID: 7680089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of interleukin-1 in human cholesteatoma.
    Ahn JM; Huang CC; Abramson M
    Am J Otolaryngol; 1990; 11(2):71-7. PubMed ID: 2188520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H; Huang CC
    Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of p27Kip1 and Ki-67 in cholesteatoma epithelium.
    Chae SW; Song JJ; Suh HK; Jung HH; Lim HH; Hwang SJ
    Laryngoscope; 2000 Nov; 110(11):1898-901. PubMed ID: 11081606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.
    Sudhoff H; Bujía J; Fisseler-Eckhoff A; Holly A; Schulz-Flake C; Hildmann H
    Laryngoscope; 1995 Nov; 105(11):1227-31. PubMed ID: 7475881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
    Raynov AM; Moon SK; Choung YH; Hong SP; Park K
    Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Junctions of squamous epithelium with middle ear mucosa.
    Palva T; Lehto VP; Virtanen I; Mäkinen J
    Acta Otolaryngol; 1985; 99(3-4):297-304. PubMed ID: 2409738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokeratin patterns of tissues related to cholesteatoma pathogenesis.
    Van Blitterswijk CA; Grote JJ; Lutgert RW; Hesseling SC; Out CJ; Van Muijen GN; Fransen JA
    Ann Otol Rhinol Laryngol; 1989 Aug; 98(8 Pt 1):635-40. PubMed ID: 2475048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative cytokeratin distribution patterns in cholesteatoma epithelium.
    Olszewska E; Sudhoff H
    Histol Histopathol; 2007 Jan; 22(1):37-42. PubMed ID: 17128409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma.
    Harabagiu OE; Cosgarea M; Mogoantă CA; Leucuţa DC; Maniu AA
    Rom J Morphol Embryol; 2017; 58(4):1333-1338. PubMed ID: 29556625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratins in induced epidermoid formations and cholesteatoma lesions.
    Vennix PP; Kuijpers W; Tonnaer EL; Peters TA; Ramaekers FC
    Arch Otolaryngol Head Neck Surg; 1990 May; 116(5):560-5. PubMed ID: 1691647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphotoxin in human middle ear cholesteatoma.
    Yan SD; Huang CC
    Laryngoscope; 1991 Apr; 101(4 Pt 1):411-5. PubMed ID: 1680210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.